Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
InoxGFL Group Plans $1bn Investment in Renewable Energy and Battery Chemicals
The InoxGFL Group plans to invest nearly $1bn across segments, including battery chemicals, green hydrogen and wind energy services, over the next three to four years, a big chunk of which will go into India’s largest battery chemicals factory it plans to build in...
Barings targets Australian businesses with $893m private credit fund
Investment firm Barings LLC, with a robust presence in the Asia Pacific region, is set to launch an Australian private credit fund, aiming to raise A$1.4bn ($893m) from institutional and high net-worth investors. Shane Forster, head of Barings' Asia Pacific private...
Investcorp to raise $274-$548m for first China-focused yuan fund
Bahrain-based alternative asset manager Investcorp is aiming to raise 2bn to 4bn yuan ($274m-$548m) for its first private equity fund in the Chinese currency, its executive said, to explore buyout opportunities in the country. Investcorp plans to apply in the next few...